NCT02665117 - Preventing Metabolic Side Effects of Thiazide Diuretics With KMgCitrate | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

November 4, 2022

Study Completion Date

November 4, 2022

Conditions

Hypertension

Interventions

DRUG

Potassium Magnesium Citrate (KMgCit)

KMgCit will be administer for 4 months with chlorthalidone.

DRUG

Potassium Chloride (KCl)

KCl will be administer for 4 months with chlorthalidone.

DRUG

Chlorthalidone

Chlorthalidone will be administered for 2-3 weeks. Then either KCL or KMgCit will be added to Chlorthalidone and the combination will be taken for 4 months.

Trial Locations (3)

75390

University of Texas Southwestern Medical Center at Dallas, Dallas

University of Texas Southwestern Medical Center, Dallas

UT Southwestern Medical Center, Dallas

All Listed Sponsors

lead

University of Texas Southwestern Medical Center

OTHER